In June 2025, the US Food and Drug Administration (FDA) announced a major update to its General Food Labeling Requirements Compliance Program—the first overhaul of this program since 2010. This ...
The US Food and Drug Administration (FDA) has released a new draft guidance describing what should and should not be included in the Drug Interactions (DIs) section for human prescription drug and ...
ImmunityBio (IBRX) added ~9% in the premarket on Wednesday after the U.S. Food and Drug Administration accepted its marketing application aimed at expanding the label of its bladder cancer therapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results